nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexfenfluramine—CYP2E1—Fingolimod—multiple sclerosis	0.245	0.261	CbGbCtD
Dexfenfluramine—CYP2A6—Prednisolone—multiple sclerosis	0.153	0.164	CbGbCtD
Dexfenfluramine—CYP2D6—Fingolimod—multiple sclerosis	0.117	0.125	CbGbCtD
Dexfenfluramine—CYP2E1—Mitoxantrone—multiple sclerosis	0.115	0.123	CbGbCtD
Dexfenfluramine—CYP2A6—Dexamethasone—multiple sclerosis	0.0905	0.0965	CbGbCtD
Dexfenfluramine—CYP2C19—Prednisone—multiple sclerosis	0.0599	0.0639	CbGbCtD
Dexfenfluramine—CYP2E1—Dexamethasone—multiple sclerosis	0.0597	0.0637	CbGbCtD
Dexfenfluramine—CYP2C19—Dexamethasone—multiple sclerosis	0.0374	0.0399	CbGbCtD
Dexfenfluramine—CYP2C9—Dexamethasone—multiple sclerosis	0.0311	0.0332	CbGbCtD
Dexfenfluramine—CYP2D6—Dexamethasone—multiple sclerosis	0.0285	0.0303	CbGbCtD
Dexfenfluramine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.78e-05	0.00157	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—S1PR1—multiple sclerosis	9.77e-05	0.00156	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—GPR65—multiple sclerosis	9.76e-05	0.00156	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—PTGER4—multiple sclerosis	9.63e-05	0.00154	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—SRM—multiple sclerosis	9.57e-05	0.00153	CbGpPWpGaD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	9.49e-05	0.00152	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—LINGO1—multiple sclerosis	9.44e-05	0.00151	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.36e-05	0.0015	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—CXCL10—multiple sclerosis	9.32e-05	0.00149	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—CXCR3—multiple sclerosis	9.3e-05	0.00149	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.28e-05	0.00149	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	9.23e-05	0.00148	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	9.23e-05	0.00148	CbGpPWpGaD
Dexfenfluramine—SLC6A4—NRF2 pathway—TGFB1—multiple sclerosis	9.16e-05	0.00147	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—RGS1—multiple sclerosis	9.15e-05	0.00147	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—CCR2—multiple sclerosis	9.05e-05	0.00145	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	8.98e-05	0.00144	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	8.94e-05	0.00143	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	8.93e-05	0.00143	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—CCR1—multiple sclerosis	8.93e-05	0.00143	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—CXCL13—multiple sclerosis	8.93e-05	0.00143	CbGpPWpGaD
Dexfenfluramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	8.9e-05	0.00142	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Biological oxidations—POMC—multiple sclerosis	8.87e-05	0.00142	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—GPR65—multiple sclerosis	8.67e-05	0.00139	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	8.5e-05	0.00136	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	8.41e-05	0.00135	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	8.41e-05	0.00135	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—CNR1—multiple sclerosis	8.35e-05	0.00134	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—RGS1—multiple sclerosis	8.31e-05	0.00133	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—TAGAP—multiple sclerosis	8.19e-05	0.00131	CbGpPWpGaD
Dexfenfluramine—SLC6A4—SIDS Susceptibility Pathways—TNF—multiple sclerosis	8.11e-05	0.0013	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—CCL5—multiple sclerosis	8.02e-05	0.00128	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—CCR1—multiple sclerosis	7.93e-05	0.00127	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—CXCL13—multiple sclerosis	7.93e-05	0.00127	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.93e-05	0.00127	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—GPR65—multiple sclerosis	7.88e-05	0.00126	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	7.65e-05	0.00123	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—LINGO1—multiple sclerosis	7.62e-05	0.00122	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—SRM—multiple sclerosis	7.56e-05	0.00121	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—CXCL10—multiple sclerosis	7.52e-05	0.0012	CbGpPWpGaD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	7.41e-05	0.00119	CbGpPWpGaD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	7.25e-05	0.00116	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—CCR5—multiple sclerosis	7.22e-05	0.00116	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—CXCL13—multiple sclerosis	7.2e-05	0.00115	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—CCR1—multiple sclerosis	7.2e-05	0.00115	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	7.19e-05	0.00115	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	7.19e-05	0.00115	CbGpPWpGaD
Dexfenfluramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	7.18e-05	0.00115	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—S1PR1—multiple sclerosis	7.15e-05	0.00115	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Biological oxidations—POMC—multiple sclerosis	7.01e-05	0.00112	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	6.99e-05	0.00112	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	6.98e-05	0.00112	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—GPC5—multiple sclerosis	6.96e-05	0.00111	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	6.84e-05	0.0011	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—PTGER4—multiple sclerosis	6.74e-05	0.00108	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—CYP27B1—multiple sclerosis	6.74e-05	0.00108	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—CYP24A1—multiple sclerosis	6.74e-05	0.00108	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—TAGAP—multiple sclerosis	6.6e-05	0.00106	CbGpPWpGaD
Dexfenfluramine—SLC6A4—SIDS Susceptibility Pathways—IL6—multiple sclerosis	6.55e-05	0.00105	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	6.51e-05	0.00104	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	6.51e-05	0.00104	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—CXCR3—multiple sclerosis	6.51e-05	0.00104	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—CCL5—multiple sclerosis	6.47e-05	0.00104	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—CCL3—multiple sclerosis	6.36e-05	0.00102	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—CCR2—multiple sclerosis	6.34e-05	0.00101	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—GPC5—multiple sclerosis	6.16e-05	0.000987	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—PTGER4—multiple sclerosis	6.12e-05	0.000981	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—RGS1—multiple sclerosis	6.08e-05	0.000974	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	5.98e-05	0.000958	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—CXCR3—multiple sclerosis	5.91e-05	0.000947	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	5.85e-05	0.000937	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—CNR1—multiple sclerosis	5.85e-05	0.000936	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—SRM—multiple sclerosis	5.83e-05	0.000934	CbGpPWpGaD
Dexfenfluramine—CYP2A6—NRF2 pathway—TGFB1—multiple sclerosis	5.83e-05	0.000933	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—CCR5—multiple sclerosis	5.83e-05	0.000933	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—S1PR1—multiple sclerosis	5.77e-05	0.000924	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—GPR65—multiple sclerosis	5.77e-05	0.000924	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—CCR2—multiple sclerosis	5.75e-05	0.000921	CbGpPWpGaD
Dexfenfluramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	5.66e-05	0.000907	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—POMC—multiple sclerosis	5.65e-05	0.000904	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—GPC5—multiple sclerosis	5.61e-05	0.000899	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—CCL2—multiple sclerosis	5.52e-05	0.000885	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—PTGER4—multiple sclerosis	5.44e-05	0.000871	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Biological oxidations—POMC—multiple sclerosis	5.41e-05	0.000866	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—SRM—multiple sclerosis	5.36e-05	0.000859	CbGpPWpGaD
Dexfenfluramine—SLC6A4—Circadian rythm related genes—IL6—multiple sclerosis	5.34e-05	0.000856	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	5.33e-05	0.000853	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	5.33e-05	0.000853	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—SRM—multiple sclerosis	5.32e-05	0.000852	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—CNR1—multiple sclerosis	5.31e-05	0.00085	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CXCL13—multiple sclerosis	5.27e-05	0.000845	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CCR1—multiple sclerosis	5.27e-05	0.000845	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—CXCL10—multiple sclerosis	5.26e-05	0.000843	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—CXCR3—multiple sclerosis	5.25e-05	0.000841	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—CCL3—multiple sclerosis	5.13e-05	0.000822	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—CCR2—multiple sclerosis	5.11e-05	0.000819	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—RRM1—multiple sclerosis	5.11e-05	0.000818	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Biological oxidations—POMC—multiple sclerosis	4.97e-05	0.000796	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—PTGER4—multiple sclerosis	4.94e-05	0.000791	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Biological oxidations—POMC—multiple sclerosis	4.93e-05	0.000789	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—RGS1—multiple sclerosis	4.91e-05	0.000786	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—GPC5—multiple sclerosis	4.87e-05	0.00078	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—CXCL10—multiple sclerosis	4.78e-05	0.000766	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—CXCR3—multiple sclerosis	4.77e-05	0.000764	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—CNR1—multiple sclerosis	4.72e-05	0.000755	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—GPR65—multiple sclerosis	4.65e-05	0.000745	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—CCR2—multiple sclerosis	4.64e-05	0.000743	CbGpPWpGaD
Dexfenfluramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	4.57e-05	0.000732	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—POMC—multiple sclerosis	4.56e-05	0.00073	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—SRM—multiple sclerosis	4.54e-05	0.000728	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—CCL5—multiple sclerosis	4.53e-05	0.000726	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—CCL2—multiple sclerosis	4.46e-05	0.000714	CbGpPWpGaD
Dexfenfluramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	4.35e-05	0.000697	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—CNR1—multiple sclerosis	4.28e-05	0.000686	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CCR1—multiple sclerosis	4.26e-05	0.000681	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CXCL13—multiple sclerosis	4.26e-05	0.000681	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—CXCL10—multiple sclerosis	4.25e-05	0.00068	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Biological oxidations—POMC—multiple sclerosis	4.21e-05	0.000674	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—CCL5—multiple sclerosis	4.12e-05	0.000659	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	4.11e-05	0.000658	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	4.11e-05	0.000658	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—CCR5—multiple sclerosis	4.08e-05	0.000654	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—RRM1—multiple sclerosis	4.04e-05	0.000646	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—IL2RA—multiple sclerosis	4.02e-05	0.000644	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.02e-05	0.000643	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—CXCL10—multiple sclerosis	3.86e-05	0.000618	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	3.78e-05	0.000605	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	3.78e-05	0.000605	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—GPC5—multiple sclerosis	3.76e-05	0.000602	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CCL3—multiple sclerosis	3.76e-05	0.000602	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	3.75e-05	0.0006	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	3.75e-05	0.0006	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—CCR5—multiple sclerosis	3.71e-05	0.000594	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.66e-05	0.000586	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—CCL5—multiple sclerosis	3.66e-05	0.000586	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—IL2RA—multiple sclerosis	3.65e-05	0.000585	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PTGER4—multiple sclerosis	3.62e-05	0.000579	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PGR—multiple sclerosis	3.56e-05	0.000571	CbGpPWpGaD
Dexfenfluramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	3.51e-05	0.000562	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CXCR3—multiple sclerosis	3.49e-05	0.00056	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CD28—multiple sclerosis	3.46e-05	0.000554	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—GPC5—multiple sclerosis	3.46e-05	0.000554	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—GPC5—multiple sclerosis	3.43e-05	0.000549	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CCR2—multiple sclerosis	3.4e-05	0.000544	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—CCL5—multiple sclerosis	3.32e-05	0.000532	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—CCR5—multiple sclerosis	3.29e-05	0.000527	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—IL2RA—multiple sclerosis	3.25e-05	0.00052	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	3.2e-05	0.000513	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	3.2e-05	0.000513	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—POMC—multiple sclerosis	3.19e-05	0.000511	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CNR1—multiple sclerosis	3.14e-05	0.000502	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.13e-05	0.000501	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—RRM1—multiple sclerosis	3.11e-05	0.000499	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CCL3—multiple sclerosis	3.03e-05	0.000486	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—CCR5—multiple sclerosis	2.99e-05	0.000479	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—IL2RA—multiple sclerosis	2.95e-05	0.000472	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—BCHE—multiple sclerosis	2.93e-05	0.00047	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GPC5—multiple sclerosis	2.93e-05	0.000469	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PTGER4—multiple sclerosis	2.92e-05	0.000467	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—POMC—multiple sclerosis	2.9e-05	0.000464	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PGR—multiple sclerosis	2.87e-05	0.00046	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—RRM1—multiple sclerosis	2.86e-05	0.000459	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—RRM1—multiple sclerosis	2.84e-05	0.000455	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—CCL2—multiple sclerosis	2.84e-05	0.000454	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CXCL10—multiple sclerosis	2.82e-05	0.000452	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CXCR3—multiple sclerosis	2.82e-05	0.000451	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CD28—multiple sclerosis	2.79e-05	0.000447	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CCR2—multiple sclerosis	2.74e-05	0.000439	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—TYK2—multiple sclerosis	2.57e-05	0.000412	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—POMC—multiple sclerosis	2.57e-05	0.000412	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CNR1—multiple sclerosis	2.53e-05	0.000405	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CD86—multiple sclerosis	2.47e-05	0.000395	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CCL5—multiple sclerosis	2.43e-05	0.000389	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—RRM1—multiple sclerosis	2.43e-05	0.000389	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.42e-05	0.000387	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—IL2—multiple sclerosis	2.36e-05	0.000378	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—POMC—multiple sclerosis	2.34e-05	0.000374	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—BCHE—multiple sclerosis	2.32e-05	0.000371	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—CCL2—multiple sclerosis	2.29e-05	0.000366	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CXCL10—multiple sclerosis	2.28e-05	0.000365	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—SPP1—multiple sclerosis	2.25e-05	0.000361	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.2e-05	0.000353	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CCR5—multiple sclerosis	2.19e-05	0.000351	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—IL2RA—multiple sclerosis	2.16e-05	0.000346	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—IL2—multiple sclerosis	2.14e-05	0.000343	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—TYK2—multiple sclerosis	2.08e-05	0.000333	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.08e-05	0.000332	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—APOE—multiple sclerosis	1.99e-05	0.000319	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CD86—multiple sclerosis	1.99e-05	0.000319	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CCL5—multiple sclerosis	1.96e-05	0.000314	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—IL2—multiple sclerosis	1.9e-05	0.000305	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.89e-05	0.000303	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.89e-05	0.000303	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.88e-05	0.000301	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—SPP1—multiple sclerosis	1.82e-05	0.000291	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CD80—multiple sclerosis	1.8e-05	0.000289	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.79e-05	0.000286	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CCR5—multiple sclerosis	1.77e-05	0.000283	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—APOE—multiple sclerosis	1.76e-05	0.000283	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—IL2RA—multiple sclerosis	1.74e-05	0.000279	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—IL2—multiple sclerosis	1.73e-05	0.000277	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.73e-05	0.000276	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—POMC—multiple sclerosis	1.71e-05	0.000274	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CCL2—multiple sclerosis	1.67e-05	0.000268	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.65e-05	0.000263	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—MAPK1—multiple sclerosis	1.64e-05	0.000262	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.63e-05	0.000261	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.62e-05	0.000259	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—APOE—multiple sclerosis	1.61e-05	0.000257	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—TYK2—multiple sclerosis	1.52e-05	0.000244	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—POMC—multiple sclerosis	1.52e-05	0.000243	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.47e-05	0.000236	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CD80—multiple sclerosis	1.45e-05	0.000233	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—APOE—multiple sclerosis	1.39e-05	0.000223	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.39e-05	0.000223	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—ALB—multiple sclerosis	1.38e-05	0.000221	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—POMC—multiple sclerosis	1.38e-05	0.000221	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CCL2—multiple sclerosis	1.35e-05	0.000216	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—MAPK1—multiple sclerosis	1.32e-05	0.000212	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—IL2—multiple sclerosis	1.27e-05	0.000203	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—IL6—multiple sclerosis	1.26e-05	0.000202	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—TYK2—multiple sclerosis	1.23e-05	0.000196	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—POMC—multiple sclerosis	1.2e-05	0.000192	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—MMP9—multiple sclerosis	1.2e-05	0.000192	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—ALB—multiple sclerosis	1.09e-05	0.000175	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—APOE—multiple sclerosis	1.08e-05	0.000172	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—STAT3—multiple sclerosis	1.06e-05	0.000171	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—IL2—multiple sclerosis	1.02e-05	0.000163	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—IL6—multiple sclerosis	1.02e-05	0.000163	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—APOE—multiple sclerosis	9.9e-06	0.000158	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—MYC—multiple sclerosis	9.9e-06	0.000158	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—TGFB1—multiple sclerosis	9.87e-06	0.000158	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—APOE—multiple sclerosis	9.81e-06	0.000157	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—MAPK1—multiple sclerosis	9.68e-06	0.000155	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MMP9—multiple sclerosis	9.66e-06	0.000155	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—POMC—multiple sclerosis	9.24e-06	0.000148	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—STAT3—multiple sclerosis	8.59e-06	0.000138	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—POMC—multiple sclerosis	8.5e-06	0.000136	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—POMC—multiple sclerosis	8.43e-06	0.000135	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—ALB—multiple sclerosis	8.43e-06	0.000135	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—APOE—multiple sclerosis	8.38e-06	0.000134	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MYC—multiple sclerosis	7.98e-06	0.000128	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—TGFB1—multiple sclerosis	7.96e-06	0.000128	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MAPK1—multiple sclerosis	7.81e-06	0.000125	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—ALB—multiple sclerosis	7.75e-06	0.000124	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—ALB—multiple sclerosis	7.68e-06	0.000123	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—IL6—multiple sclerosis	7.44e-06	0.000119	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—POMC—multiple sclerosis	7.2e-06	0.000115	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ALB—multiple sclerosis	6.57e-06	0.000105	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—IL6—multiple sclerosis	6e-06	9.61e-05	CbGpPWpGaD
